Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jun;9(1):55-69.
doi: 10.1007/s40122-020-00151-x. Epub 2020 Jan 28.

Kratom-Pharmacology, Clinical Implications, and Outlook: A Comprehensive Review

Affiliations
Review

Kratom-Pharmacology, Clinical Implications, and Outlook: A Comprehensive Review

Steven C Eastlack et al. Pain Ther. 2020 Jun.

Abstract

Kratom, or Mitragyna, is a tropical plant indigenous to Southeast Asia, with unique pharmacological properties. It is commonly consumed by preparing the leaves into decoction or tea, or by grinding them into a powder. Recent evidence has revealed that kratom has physiological effects similar to opioids, including pain relief and euphoria, as well as stimulant properties, which together raise potential concern for dependence and addiction. Moreover, growing evidence suggests that the prevalence of kratom use is increasing in many parts of the world, raising important considerations for healthcare providers. This manuscript will discuss the most current epidemiology, pharmacology, toxicity, and management related to kratom, while seeking to provide a contemporary perspective on the issue and its role in the greater context of the opioid epidemic.

Keywords: Drug abuse; Drug addiction; Kratom; Mitragynine; Opioid; Stimulant.

PubMed Disclaimer

Conflict of interest statement

Steven C. Eastlack and Elyse M. Cornett have nothing to disclose. Alan David Kaye is a member of the journal’s Editorial Board.

Figures

Fig. 1
Fig. 1
Key considerations regarding kratom in the medical field. Figure is original and was produced by the authors for this particular publication

References

    1. Suwanlert S. A study of kratom eaters in Thailand. Bull Narc. 1975;27(3):21–27. - PubMed
    1. Davis A. Rubiaceae of Thailand—a pictorial guide to indigenous and cultivated genera. Bot J Linn Soc. 2006;152(1):131–132. doi: 10.1111/j.1095-8339.2006.00553.x. - DOI
    1. Jansen KL, Prast CJ. Ethnopharmacology of kratom and the Mitragyna alkaloids. J Ethnopharmacol. 1988;23(1):115–119. doi: 10.1016/0378-8741(88)90121-3. - DOI - PubMed
    1. Henningfield JE, Fant RV, Wang DW. The abuse potential of kratom according the 8 factors of the controlled substances act: implications for regulation and research. Psychopharmacology. 2018;235(2):573–589. doi: 10.1007/s00213-017-4813-4. - DOI - PMC - PubMed
    1. Singh D, Narayanan S, Vicknasingam B, Corazza O, Santacroce R, Roman-Urrestarazu A. Changing trends in the use of kratom (Mitragyna speciosa) in Southeast Asia. Hum Psychopharmacol Clin Exp. 2017;32(3):e2582. doi: 10.1002/hup.2582. - DOI - PubMed

LinkOut - more resources